Business Description
22nd Century Group, Inc., an agricultural biotechnology company, focuses on tobacco harm reduction, reduced nicotine tobacco, and enhancing health and wellness through plant science for the life science and consumer products industries. It develops very low nicotine content tobacco and cigarette products under the VLN King and VLN Menthol King names; and SPECTRUM research cigarettes for use in independent clinical studies. The company has collaboration with Keygene N.V. to develop hemp/cannabis plants for exceptional cannabinoid profiles and other superior agronomic traits for medical, therapeutic, and agricultural uses, as well as other applications. 22nd Century Group, Inc. was founded in 1998 and is headquartered in Buffalo, New York.
Business History
Revenue & Net Income Trend
| Period | Revenue | Net Income | Net Margin | YoY/QoQ |
|---|
Key Metrics
EPS (Diluted): -52.87
Total Equity: $15.76M
Shares: 184,067
Total Debt: $3.61M
Cash: $7.15M
EBITDA: -$10.26M
Total Debt: $3.61M
Cash: $7.15M
Revenue: $17.59M
Revenue: $17.59M
Revenue: $17.59M
Total Equity: $15.76M
Tax Rate: 0.2%
Equity: $15.76M
Total Debt: $3.61M
Cash: $7.15M
Current Liabilities: $7.27M
Long-Term Debt: $3.24M
Total Debt: $3.61M
Total Equity: $15.76M
Shares: 184,067
Shares: 184,067
CapEx: -$875,000
Shares: 184,067
Stock Price: $0.63
Net Income: -$5.05M
Industry Benchmarks
Deep Analysis
Pre-flight intelligence scans the company first, then routes to the right analytical methods.
Income Statement (Annual)
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $30.9M | $40.5M | $32.2M | $11.9M | $17.6M |
| Cost of Revenue | $29.5M | $38.7M | $40.9M | $14.3M | $21.1M |
| Gross Profit | $1.5M | $1.8M | -$8.7M | -$2.4M | -$3.6M |
| Operating Expenses | $29.9M | $35.5M | $36.2M | $11.6M | $7.9M |
| Operating Income | -$28.4M | -$33.6M | -$44.9M | -$14.0M | -$11.4M |
| Net Income | -$32.6M | -$59.8M | -$140.8M | -$15.2M | -$5.1M |
| EBITDA | -$31.0M | -$32.9M | -$40.4M | -$12.1M | -$10.3M |
| EPS | $-2,329,214.29 | $-3,147,421.05 | $-2,599,431.03 | $-12,035.44 | $-52.87 |
| EPS (Diluted) | — | — | — | — | — |
Balance Sheet (Annual)
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | $1.3M | $2.2M | $2.1M | $4.4M | $7.1M |
| Total Current Assets | $54.4M | $44.6M | $16.3M | $11.5M | $17.6M |
| Total Assets | $76.0M | $114.7M | $27.5M | $21.7M | $27.0M |
| Current Liabilities | $8.4M | $13.0M | $25.0M | $10.0M | $7.3M |
| Long-Term Debt | $0 | $3.0M | $8.1M | $5.2M | $3.2M |
| Total Liabilities | $9.9M | $18.7M | $35.9M | $17.7M | $11.3M |
| Total Equity | $66.1M | $96.0M | -$8.4M | $4.0M | $15.8M |
| Retained Earnings | -$178.0M | -$237.8M | -$378.7M | -$393.9M | -$398.9M |
Cash Flow (Annual)
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Operating Cash Flow | -$22.8M | -$51.7M | -$55.0M | -$14.3M | -$7.7M |
| Capital Expenditure | -$1.1M | -$4.4M | -$5.6M | $-161,000 | $-875,000 |
| Free Cash Flow | -$23.9M | -$56.1M | -$60.6M | -$14.5M | -$8.6M |
| Acquisitions (net) | $326,000 | -$2.0M | $411,000 | $0 | $0 |
| Debt Repayment | — | — | — | — | — |
| Dividends Paid | — | — | — | — | — |
| Stock Buybacks | $0 | $0 | $-178,000 | $0 | $0 |
| Net Change in Cash | $307,000 | $1.7M | $-962,000 | $2.4M | $2.7M |
Analyst Estimates (Annual)
| Metric | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Revenue |
$19.3M $19.3M – $19.3M
|
$33.5M $33.5M – $33.5M
|
$18.1M $18.1M – $18.1M
|
$32.5M $32.5M – $32.5M
|
| EBITDA |
-$17.0M -$17.0M – -$17.0M
|
-$29.5M -$29.5M – -$29.5M
|
-$15.9M -$15.9M – -$15.9M
|
-$28.6M -$28.6M – -$28.6M
|
| Net Income |
-$6.2M -$6.2M – -$6.2M
|
-$170.1B -$170.1B – -$170.1B
|
-$1.7M -$1.7M – -$1.7M
|
$-165,661 $-165,661 – $-165,661
|
| EPS | — | — | — | — |
Growth Trends (YoY %)
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Revenue Growth | +30.9% | -20.5% | -63.1% | +48.1% |
| Gross Profit Growth | +24.3% | -570.8% | +72.4% | -48.3% |
| Operating Income Growth | -18.4% | -33.6% | +69.0% | +18.2% |
| Net Income Growth | -83.4% | -135.4% | +89.2% | +66.7% |
| EBITDA Growth | -6.1% | -22.9% | +70.0% | +15.3% |